119 related articles for article (PubMed ID: 23592439)
21. Tat conjugation of adenovirus vector broadens tropism and enhances transduction efficiency.
Yoshioka Y; Asavatanabodee R; Eto Y; Watanabe H; Morishige T; Yao X; Kida S; Maeda M; Mukai Y; Mizuguchi H; Kawasaki K; Okada N; Nakagawa S
Life Sci; 2008 Nov; 83(21-22):747-55. PubMed ID: 18930744
[TBL] [Abstract][Full Text] [Related]
22. Manipulation of the cytoplasmic and transmembrane domains alters cell surface levels of the coxsackie-adenovirus receptor and changes the efficiency of adenovirus infection.
van't Hof W; Crystal RG
Hum Gene Ther; 2001 Jan; 12(1):25-34. PubMed ID: 11177539
[TBL] [Abstract][Full Text] [Related]
23. Marine Lectins DlFBL and HddSBL Fused with Soluble Coxsackie-Adenovirus Receptor Facilitate Adenovirus Infection in Cancer Cells BUT Have Different Effects on Cell Survival.
Wu B; Mei S; Cui L; Zhao Z; Chen J; Wu T; Li G
Mar Drugs; 2017 Mar; 15(3):. PubMed ID: 28335432
[TBL] [Abstract][Full Text] [Related]
24. Efficient Adenovirus Gene Transfer Methods in Human Colonic Caco-2 Epithelial Cells Using Capric Acid.
Koizumi N; Yamagishi Y; Hirai T; Fujii M; Mizuguchi H; Watanabe Y
Biol Pharm Bull; 2015; 38(8):1240-4. PubMed ID: 26235589
[TBL] [Abstract][Full Text] [Related]
25. Coxsackie and adenovirus receptor binding ablation reduces adenovirus liver tropism and toxicity.
Yun CO; Yoon AR; Yoo JY; Kim H; Kim M; Ha T; Kim GE; Kim H; Kim JH
Hum Gene Ther; 2005 Feb; 16(2):248-61. PubMed ID: 15761264
[TBL] [Abstract][Full Text] [Related]
26. Adenoviral gene vector tethering to nanoparticle surfaces results in receptor-independent cell entry and increased transgene expression.
Chorny M; Fishbein I; Alferiev IS; Nyanguile O; Gaster R; Levy RJ
Mol Ther; 2006 Sep; 14(3):382-91. PubMed ID: 16807119
[TBL] [Abstract][Full Text] [Related]
27. Targeting of high-capacity adenoviral vectors.
Biermann V; Volpers C; Hussmann S; Stock A; Kewes H; Schiedner G; Herrmann A; Kochanek S
Hum Gene Ther; 2001 Sep; 12(14):1757-69. PubMed ID: 11560769
[TBL] [Abstract][Full Text] [Related]
28. Cell-penetrating peptides (CPPs) as a vector for the delivery of siRNAs into cells.
Nakase I; Tanaka G; Futaki S
Mol Biosyst; 2013 May; 9(5):855-61. PubMed ID: 23306408
[TBL] [Abstract][Full Text] [Related]
29. Modified adenoviral vectors ablated for coxsackievirus-adenovirus receptor, alphav integrin, and heparan sulfate binding reduce in vivo tissue transduction and toxicity.
Koizumi N; Kawabata K; Sakurai F; Watanabe Y; Hayakawa T; Mizuguchi H
Hum Gene Ther; 2006 Mar; 17(3):264-79. PubMed ID: 16544976
[TBL] [Abstract][Full Text] [Related]
30. Targeted adenovirus vectors.
Mizuguchi H; Hayakawa T
Hum Gene Ther; 2004 Nov; 15(11):1034-44. PubMed ID: 15610604
[TBL] [Abstract][Full Text] [Related]
31. Fiber knob modifications overcome low, heterogeneous expression of the coxsackievirus-adenovirus receptor that limits adenovirus gene transfer and oncolysis for human rhabdomyosarcoma cells.
Cripe TP; Dunphy EJ; Holub AD; Saini A; Vasi NH; Mahller YY; Collins MH; Snyder JD; Krasnykh V; Curiel DT; Wickham TJ; DeGregori J; Bergelson JM; Currier MA
Cancer Res; 2001 Apr; 61(7):2953-60. PubMed ID: 11306473
[TBL] [Abstract][Full Text] [Related]
32. Effective gene transfer to human melanomas via integrin-targeted adenoviral vectors.
Nakamura T; Sato K; Hamada H
Hum Gene Ther; 2002 Mar; 13(5):613-26. PubMed ID: 11916485
[TBL] [Abstract][Full Text] [Related]
33. Hexon-specific PEGylated adenovirus vectors utilizing avidin-biotin interaction.
Suzuki-Kouyama E; Katayama K; Sakurai F; Yamaguchi T; Kurachi S; Kawabata K; Nakagawa S; Mizuguchi H
Biomaterials; 2011 Feb; 32(6):1724-30. PubMed ID: 21106235
[TBL] [Abstract][Full Text] [Related]
34. A baculoviral display system to assay viral entry.
Iida M; Yoshida T; Watari A; Yagi K; Hamakubo T; Kondoh M
Biol Pharm Bull; 2013; 36(11):1867-9. PubMed ID: 24189431
[TBL] [Abstract][Full Text] [Related]
35. Gene delivery into malignant glioma by infectivity-enhanced adenovirus: in vivo versus in vitro models.
Van Houdt WJ; Wu H; Glasgow JN; Lamfers ML; Dirven CM; Gillespie GY; Curiel DT; Haviv YS
Neuro Oncol; 2007 Jul; 9(3):280-90. PubMed ID: 17522331
[TBL] [Abstract][Full Text] [Related]
36. Transductional and transcriptional targeting of adenovirus for clinical applications.
Glasgow JN; Bauerschmitz GJ; Curiel DT; Hemminki A
Curr Gene Ther; 2004 Mar; 4(1):1-14. PubMed ID: 15032610
[TBL] [Abstract][Full Text] [Related]
37. Transduction and apoptosis induction in the rat prostate, using adenovirus vectors.
Kirkman W; Chen P; Schroeder R; Feneley MR; Rodriguez R; Wickham TJ; King CR; Bruder JT
Hum Gene Ther; 2001 Aug; 12(12):1499-512. PubMed ID: 11506693
[TBL] [Abstract][Full Text] [Related]
38. Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice.
Smith TA; Idamakanti N; Rollence ML; Marshall-Neff J; Kim J; Mulgrew K; Nemerow GR; Kaleko M; Stevenson SC
Hum Gene Ther; 2003 May; 14(8):777-87. PubMed ID: 12804140
[TBL] [Abstract][Full Text] [Related]
39. A vesicular stomatitis virus glycoprotein epitope-incorporated oncolytic adenovirus overcomes CAR-dependency and shows markedly enhanced cancer cell killing and suppression of tumor growth.
Yoon AR; Hong J; Yun CO
Oncotarget; 2015 Oct; 6(33):34875-91. PubMed ID: 26430798
[TBL] [Abstract][Full Text] [Related]
40. Binding of adenoviral fiber knob to the coxsackievirus-adenovirus receptor is crucial for transduction of fetal muscle.
Bilbao R; Srinivasan S; Reay D; Goldberg L; Hughes T; Roelvink PW; Einfeld DA; Wickham TJ; Clemens PR
Hum Gene Ther; 2003 May; 14(7):645-9. PubMed ID: 12804146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
